Invention Grant
- Patent Title: Determining the bioavailability of zinc (II) ions
-
Application No.: US14580485Application Date: 2014-12-23
-
Publication No.: US09625449B2Publication Date: 2017-04-18
- Inventor: Stanislav Jaracz , Harsh M. Trivedi , Lyndsay Schaeffer-Korbylo , Lynette Zaidel
- Applicant: Colgate-Palmolive Company
- Applicant Address: US NY New York
- Assignee: Colgate-Palmolive Company
- Current Assignee: Colgate-Palmolive Company
- Current Assignee Address: US NY New York
- Main IPC: G01N21/78
- IPC: G01N21/78 ; G01N33/84 ; G01N33/50

Abstract:
An in vitro method for determining the bioavailability of zinc (II) ions from an oral care composition comprises: providing a sample comprising, the oral care composition; contacting the sample with a biorelevant substrate, separating the biorelevant substrate from the sample, contacting the biorelevant substrate with an indicator under conditions selected such that the indicator is capable of reacting with zinc (II) ions, and determining a light absorbance of the indicator. The indicator is zincon or a salt thereof. The method is useful for estimating the ability of an oral care composition to deliver therapeutically-active zinc (II) ions to the oral cavity. Also provided is the use of zincon and a biorelevant substrate in vitro to determine the bioavailability of zinc (II) ions from an oral care composition comprising, a zinc source.
Public/Granted literature
- US20160178617A1 DETERMINING THE BIOAVAILABILITY OF ZINC (II) IONS Public/Granted day:2016-06-23
Information query